Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation (MaasFlex)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03721874
Recruitment Status : Recruiting
First Posted : October 26, 2018
Last Update Posted : November 6, 2020
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Patrick Schrauwen, Maastricht University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : November 2021